Why Tilray Stock Rallied After its Q3 Results

Here’s why Tilray (TSX:TLRY) stock jumped sharply after announcing its Q3 results.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What happened?

The shares of Tilray (TSX:TLRY)(NASDAQ:TLRY) rose sharply on Wednesday after the company announced the results for Q3 of its fiscal year 2022. During the intraday trading, the TSX-listed TLRY stock jumped by about 16% yesterday before paring some of the gains in the latter half of the session, as the broader market selloff intensified.

So what?

In the third quarter ended in February 2022, Tilray registered 23% YoY (year-over-year) positive growth in its total revenue to around US$151.9 million. However, its latest quarterly revenue figure missed analysts’ estimate of US$156.8 million by a narrow margin.  While its cannabis segment revenue jumped by 32% YoY, the company registered solid 64% growth in its beverage alcohol revenue. In addition, Tilray’s international market cannabis revenue saw a massive increase.

Despite its lower-than-expected revenue, the cannabis giant pleasantly surprised investors by reporting a second consecutive profitable quarter. Tilray’s Q3 adjusted earnings stood at around US$0.09 per share against Street’s expectation of US$0.08-per-share loss. The company cited a reduction in its “assessment of the contingent consideration owed on the SweetWater transaction” as one of the factors that impacted its profits in the February quarter. These factors seemingly helped the company regain investors’ confidence, triggering a rally in TLRY stock price.

Now what?

Currency headwinds stole about US$7 million from Tilray’s distribution segment revenue in the last quarter as the euro continues to weaken against the U.S. dollar. Apart from this temporary negative factor, Tilray’s latest quarterly financial results largely reflected strong positive growth.

After the completion of the Aphria-Tilray merger in May 2021, Tilray has achieved nearly US$76 million in cost synergies. By the end of May 2022, the company expects to reach its goal of achieving US$80 million Synergy — way ahead of schedule. Also, a massive recent rise in its international market revenue reflects optimism for Tilray’s long-term business growth.

Given these positive developments, long-term investors may consider buying TLRY stock right now. Despite yesterday’s sharp rally, Tilray stock continues to underperform the main Canadian market gauge, as it’s trading with only 2% year-to-date gains.

Should you invest $1,000 in Enbridge right now?

Before you buy stock in Enbridge, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Enbridge wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool has no position in any of the stocks mentioned. Fool contributor Jitendra Parashar has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »